$0.03
$-0.01 (-25.00%)
End-of-day quote: 04/04/2023
NasdaqGM:VIVO
Meridian Bioscience Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $547.25 | $591.94 | 0.00% | 1 | $208.89B |
| ROG | Roche Holding | SWX | Hold | CHF220.10 | CHF307.83 | 0.00% | 9 | CHF177.32B |
| ABT | Abbott Laboratories | NYSE | Outperform | $105.90 | $118.92 | 0.00% | 7 | $183.76B |
| DHR | Danaher | NYSE | Outperform | $239.39 | $260.33 | 0.00% | 4 | $177.28B |
| SIE | Siemens | XTRA | Outperform | 172.68€ | 178.14€ | 0.00% | 11 | 135.40€B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $232.21 | $284.47 | 0.00% | 8 | $67.09B |
| ILMN | Illumina | NasdaqGS | Outperform | $118.29 | $159.28 | 0.00% | 9 | $18.84B |
| BIM | bioMérieux | ENXTPA | Outperform | 100.10€ | 105.55€ | 0.00% | 1 | 11.83€B |
| TECH | Bio-Techne Corp | NASDAQ | Buy | $62.73 | $100.78 | 0.00% | 2 | $9.86B |
| MYGN | Myriad Genetics | NasdaqGS | Hold | $18.64 | $22.08 | 0.00% | 8 | $2.08B |
| OSUR | OraSure Technologies | NasdaqGS | Hold | $5.25 | $7.40 | 0.00% | 4 | $516.59M |
| BCART | Biocartis Group NV | ENXTBR | Outperform | 0.29€ | 1.10€ | 0.00% | 0 | 27.24€M |
| TRIB | Trinity Biotech | NasdaqGS | - | $1.84 | $3.00 | 0.00% | 0 | $24.08M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $0.74 | $5.00 | 0.00% | 1 | $21.49M |
| OPGN | OpGen | NasdaqCM | $0.60 | $3.00 | 0.00% | 1 | $4.61M |
